DrugPatentWatch Database Preview
Drugs in Development Information for PQR309
Email this page to a colleague
What is the development status for investigational drug PQR309?
PQR309 is an investigational drug.
There have been 9 clinical trials for PQR309.
The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2018.
The most common disease conditions in clinical trials are Lymphoma, Lymphoma, Non-Hodgkin, and Glioblastoma. The leading clinical trial sponsors are PIQUR Therapeutics AG, University Hospital, Basel, Switzerland, and Roswell Park Cancer Institute.
There are ten US patents protecting this investigational drug and eighty-seven international patents.
Summary for PQR309
| US Patents | 10 |
| International Patents | 87 |
| US Patent Applications | 37 |
| WIPO Patent Applications | 58 |
| Japanese Patent Applications | 8 |
| Clinical Trial Progress | Phase 1 (2018-12-01) |
| Vendors | 29 |
Recent Clinical Trials for PQR309
| Title | Sponsor | Phase |
|---|---|---|
| Study Evaluating Safety and Efficacy of Bimiralisib in Patients With Head and Neck Squameous Cell Carcinoma | PIQUR Therapeutics AG | Phase 2 |
| PQR309 in Phase 2 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma | PIQUR Therapeutics AG | Phase 2 |
| Phase 2 Study With PQR309 in Relapsed or Refractory Lymphoma Patients | Charite University, Berlin, Germany | Phase 2 |
Clinical Trial Summary for PQR309
Top disease conditions for PQR309
Top clinical trial sponsors for PQR309
US Patents for PQR309
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| PQR309 | Get Started Free | Manufacturing process for triazine, pyrimidine and pyridine derivatives | UNIVERSITAET BASEL (Basel, CH) PIQUR THERAPEUTICS AG (Basel, CH) | Get Started Free |
| PQR309 | Get Started Free | Uses of indolinone compounds | Oncternal Therapeutics, Inc. (San Diego, CA) | Get Started Free |
| PQR309 | Get Started Free | Compositions of CXCR4 inhibitors and methods of preparation and use | X4 PHARMACEUTICALS, INC. (Cambridge, MA) | Get Started Free |
| PQR309 | Get Started Free | Crystalline forms | Array Biopharma Inc. (Boulder, CO) | Get Started Free |
| PQR309 | Get Started Free | Compounds for treating cancer | BICYCLERD LIMITED (Cambridge, GB) | Get Started Free |
| PQR309 | Get Started Free | Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines | PIQUR THERAPEUTICS AG (Basel, CH) UNIVERSITAT BASEL (Basel, CH) | Get Started Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for PQR309
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| PQR309 | Australia | AU2015250994 | 2034-04-22 | Get Started Free |
| PQR309 | Brazil | BR112016023811 | 2034-04-22 | Get Started Free |
| PQR309 | Canada | CA2944697 | 2034-04-22 | Get Started Free |
| PQR309 | China | CN106458968 | 2034-04-22 | Get Started Free |
| PQR309 | European Patent Office | EP3134388 | 2034-04-22 | Get Started Free |
| PQR309 | Spain | ES2713452 | 2034-04-22 | Get Started Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
